naphthalimides has been researched along with Uterine Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbury, R; Blessing, JA; Buller, R; Malfetano, JH; Sevin, BU; Walker, J | 1 |
| Asbury, R; Ball, H; Blessing, JA; Podczaski, E | 1 |
2 trial(s) available for naphthalimides and Uterine Neoplasms
| Article | Year |
|---|---|
Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Leiomyosarcoma; Middle Aged; Naphthalimides; Organophosphonates; Uterine Neoplasms | 1998 |
A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Leukopenia; Middle Aged; Mixed Tumor, Mesodermal; Naphthalimides; Organophosphonates; Thrombocytopenia; Uterine Neoplasms | 1998 |